ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers

October 9, 1998

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980